Any thoughts on what might be the likely effect if funding is via convertible note with Springtree?
I haven't followed these events closely, but when PRR entered their agreement in 2009, SP didn't change much until announcements flowed over the following months.
But the market seemed to view the Neuren funding from Springtree as a drag on sp and reacted positively when it was finished this year.
ACL has different needs to PRR (shorter funding period, high initial funds. What's a likely set of conditions if it is through Springtree?
If ACL can show evidence of initial cash flow from fonda, is a straight loan likely? Or is there still too much perceived risk for a bank to get involved?
- Forums
- ASX - By Stock
- TSN
- acl funding
acl funding, page-2
-
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online